Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06392568
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-03-30
Brief Title:
Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units
Sponsor:
Abderrahmane Mami Hospital
Organization:
Abderrahmane Mami Hospital
Study Overview
Official Title:
Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units A Prospective Multicenter National Observational Study NOSOREA-3
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NOSOREA3
Brief Summary:
Investigate the epidemiology risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant eHDR pathogens particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus
Detailed Description:
In 2022 a previous one-day point-prevalence multicenter study NOSOREA2 NCT05547646 showed that most prevalent pathogens causing healthcare-associated infections were carbapenem resistant enterobacteriaceae In 2017 NOSOREA1 LA TUNISIE MEDICALE - 2018 Vol 96 1011 most prevalent pathogens were non-fermenting pathogens
Faced with this major epidemiological change within Tunisian ICUs we decided to launch a 3rd survey under the aegis of the Association tunisienne de réanimation We aimed to investigate the epidemiology risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant eHDR pathogens particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus So we conducted a multicenter prospective collection that will take place over 2 months
Faced with this major epidemiological change within Tunisian ICUs we decided to launch a 3rd survey under the aegis of the Association tunisienne de réanimation We aimed to investigate the epidemiology risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant eHDR pathogens particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus So we conducted a multicenter prospective collection that will take place over 2 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None